bosentan anhydrous has been researched along with Leg Ulcer in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de la Prada-Alvarez, F; Fraga, GR; García-Fuentes, F; Gil-Gascón, JM; Guerrero-Cauqui, R; Wetmore, JB | 1 |
Aractingi, S; Bachmeyer, C; Girot, R; Lionnet, F; Stankovic, K; Tharaux, PL | 1 |
Ferreira, ME; Scheinberg, MA | 1 |
Asano, Y; Hoashi, T; Kogure, A; Masuda, S; Mitsui, H; Miyagawa, T; Noda, S; Sato, S; Sugaya, M; Sugita, M; Tamaki, Z; Yamamoto, M | 1 |
Belamarich, PF; Ilowite, NT; Kenney-Riley, KM; Wahezi, DM | 1 |
5 other study(ies) available for bosentan anhydrous and Leg Ulcer
Article | Year |
---|---|
Bosentan for the treatment of a clinical syndrome closely resembling calcific uremic arteriolopathy: a case report.
Topics: Aged; Bosentan; Endothelin Receptor Antagonists; Female; Humans; Leg Ulcer; Sulfonamides; Uremia; Vascular Calcification; Wound Healing | 2014 |
Efficacy of the endothelin receptor blocker bosentan for refractory sickle cell leg ulcers.
Topics: Anemia, Sickle Cell; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Female; Humans; Leg Ulcer; Middle Aged; Sulfonamides | 2008 |
Successful treatment with bosentan of non-digital skin ulcers in severe scleroderma.
Topics: Bosentan; Endothelin Receptor Antagonists; Female; Humans; Leg Ulcer; Middle Aged; Scleroderma, Systemic; Sulfonamides | 2008 |
Bosentan: a novel therapy for leg ulcers in Werner syndrome.
Topics: Bosentan; Combined Modality Therapy; Debridement; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelin Receptor Antagonists; Follow-Up Studies; Humans; Leg Ulcer; Male; Middle Aged; Occlusive Dressings; Receptors, Endothelin; Severity of Illness Index; Sulfonamides; Treatment Outcome; Werner Syndrome; Wound Healing | 2011 |
Chronic leg ulceration as the presenting feature of diffuse systemic sclerosis in childhood.
Topics: Adolescent; Bosentan; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Leg Ulcer; Nifedipine; Scleroderma, Systemic; Sulfonamides; Vasodilator Agents | 2011 |